BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:55:50 PM | Browse: 7 | Download: 22
 |
Received |
|
2025-01-07 08:49 |
|
Peer-Review Started |
|
2025-01-07 08:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-01-18 10:09 |
|
Revised |
|
2025-01-23 18:00 |
|
Second Decision |
|
2025-02-10 02:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-02-10 05:45 |
|
Articles in Press |
|
2025-02-10 05:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-02-17 14:31 |
|
Typeset the Manuscript |
|
2025-03-27 08:25 |
|
Publish the Manuscript Online |
|
2025-07-14 12:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Enhancing T-cell response with monoclonal antibodies and chemotherapy in advanced gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ana Carolina Pires and Pedro Luiz Serrano Uson Junior |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pedro Luiz Serrano Uson Junior, Assistant Professor, MD, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenida Albert Einstein 627, São Paulo 05652900, Brazil. pedro.serrano@einstein.br |
| Key Words |
Gastric cancer; Oxaliplatin; Trastuzumab; CD4; CD8 |
| Core Tip |
After six cycles of treatment with chemotherapy and trastuzumab it was observed that the levels of tumor markers in the blood significantly dropped compared to their initial values. Furthermore, there was a notable increase in the percentages of CD3+ and CD4+ T cells, with the CD4+/CD8+ ratio also increasing after the treatment. Patients who had a reduction of 50% or more in their tumor markers and an increase in the CD4+/CD8+ ratio showed better disease outcomes. These findings can be related to the current field of advancements in the treatment of HER-2 positive gastric cancer, with the combination of immune checkpoint inhibitors. |
| Publish Date |
2025-07-14 12:55 |
| Citation |
<p>Pires AC, Uson Junior PLS. Enhancing T-cell response with monoclonal antibodies and chemotherapy in advanced gastric cancer. <i>World J Gastrointest Oncol</i> 2025; 17(7): 104806</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/104806.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.104806 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
